Episode 2 – ‘Don’t hesitate’: Biosimilars for rheumatoid arthritis

“The complexity of a biologic molecule is such that it’s impossible to make exact copies.” Professor Peter Taylor and Professor Hans Bijlsma consider anti-TNF biosimilars – the regulatory process, guidelines, uptake within healthcare systems and the resulting impact on patient health and wellbeing.